Featured In
Let's Connect
If you're a member of the media and would like to talk, please get in touch with us via an email to
Recent Coverage
- Virtual Reality Puts Drug Researchers Inside the Molecules They StudyThe immersive technology reveals clues about how compounds might work, with the aim of speeding up the drug-discovery process.
- Video: Getting up close and personal with molecules in virtual realityVirtual-reality tools let chemists explore proteins and molecules, build and test potential drugs, and collaborate with colleagues remotely. In this video, C&EN reporter Sam Lemonick tries out a VR app that incorporates visualizations of molecules with advanced computational tools—offering a new way for chemists to develop drugs and address other problems—and learns how VR could help scientists use robotic lab equipment.
- VR for Science: Drug Discovery and More in the Virtual WorldThe ability for scientists across the world to work together toward a common goal has been significantly bolstered by the advent of computer technology and the internet. Researchers can now take their questions and ideas from the lab to the web, where many minds can collaborate to provide fresh insight, and build upon models and data available to them on their screen.
- How Scientists are Using VR to Study the CoronavirusResearcher Andrey Kovalevsky often dons an Oculus Rift S virtual reality headset as part of his work studying new ways to combat Covid-19. His research team is working on one of the many remaining mysteries surrounding the coronavirus: how to shut down one of the viral proteins that would stop it from reproducing.
- See How Virtual Reality Is Helping Scientists Collaborate On Drug Design And Discovery“Part of our work in translational science involves the discovery of new medicines to treat human disease,” said David Pardoe, Head of technology development, LifeArc. “We use computers to visualise the structure of proteins we want to a potential drug to interact with - imagine this to be a lock (the protein) and key (the drug); when the key fits the lock you can open the door (or the drug does something to the protein which causes the desired therapeutic effect).”
- DEMO: Nanome Triggers Deep Drug Development Insights Via Virtual Molecule DesignIf you equate virtual reality (VR) to games or pain relief applications, you’re missing one of science’s most amazing tools. More than a dozen mostly large pharmaceutical companies and more than 250 academic sites are using VR meaningfully in scientific endeavors in molecular design and drug development.
- How Virtual Reality is Helping Scientists in the Fight Against Covid-19Steve McCloskey, CEO of Nanome, joins 'Cheddar Innovates' to discuss how Nanome's virtual reality software is being used in the fight against the coronavirus, climate change, and so much more.
- Nanome raises $3 million to help scientists get up close with molecular structures in VRDiscovery and research of new molecular compounds is an expensive business, with development costs exceeding $10 billion per substance in some cases. Part of that comes from the need to closely examine every relevant molecule, studying its chemical composition and interactions as well as its physical structure at the atomic level. Despite advances in software to help model these compounds and molecules, there are still challenges in fully understanding their shapes through a two-dimensional computer screen.
- VR Startup Nanome Raises $3m With Support From Oculus Co-FounderTeams looking for ways to collaborate through virtual reality (VR) have got an abundance of apps available like Glue, Spatial, Hubs, and Vive XR Suite to name a few. When it comes to specialised scientific research there’s Nanome, which has just announced the closure of a successful funding round raising $3 million USD.
- How Two VIVE X Companies are Helping Students and Researchers Learn RemotelyIntroduces two Vive X companies facilitating remote learning, including Nanome.
- How virtual reality and high-performance scientific computing are helping scientists understand how COVID-19 behavesOn Thursday February 20th, Dr Michael Kuiper stepped into cryo-EM 2019-nCoV spike protein structure of COVID-19. The virus had infiltrated a protein within its host, utilising its uniquely virulent composition to take over.
- The Coronavirus and Virtual RealityAn overview of COVID-19's impact on VR industry, including the collaboration sector and Nanome.
- Dr. Zoran Radić, a UC San Diego scientific researcher, uses VR to explore treatments to a deadly nerve agentFor most of his career, Radić has analyzed AChE using traditional methods. But in the last three years, a virtual reality tool by San Diego company Nanome has allowed his research to leap forward. With Nanome’s VR tool, he can – virtually – manipulate AChE, study its interactions with other molecules, present his research in a more accessible and visible way, even collaborate with other researchers remotely in the VR space.
Press Releases
- San Diego-based virtual reality startup becomes first US-based company to join EU government supercomputing efforts against SARS-CoV-2Nanome Inc., a virtual reality software startup, has joined Exscalate4Cov (E4C), a coordinated supercomputing project funded by the European Union (EU) Commission to screen chemical libraries for potential activity against SARS-CoV-2 (the coronavirus that causes COVID-19). E4C has €3 million of emergency EU funding and has already tested 9,000 drugs and bioactives, more than 100 of which have been found to be active in vitro.
- Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19Nanome, Inc., a virtual reality (VR) startup whose signature product is a computational chemistry software platform, has co-authored a paper describing 10 potential small molecule inhibitors targeting the SARS-CoV-2 main protease that were generated by artificial intelligence (AI). The study was conducted in collaboration with Insilico Medicine, an artificial intelligence company based in Hong Kong, and could reveal as-yet-undiscovered methods for attacking the virus that have eluded scientists working with existing drug candidates.
- Nanome Partners with Science Exchange to Offer Virtual Reality Drug Design Tools and Blockchain Solutions to ScientistsScience Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced a partnership with Nanome Inc. to offer scientists on-demand access to Nanome’s blockchain and virtual reality technology.
- Airbitz Rebrands, Partners with Matryx to Bring Digital Token to Virtual RealityEdge (formerly Airbitz), is bringing blockchain to virtual reality in a new partnership with Matryx, a platform for decentralized collaboration currently based on the UC San Diego campus. Matryx, which is a project of the biotechnology firm Nanome Inc., will use Edge technology as a secure identity framework on its multiple virtual-reality-for-science platforms.
About Nanome
Nanome is the first virtual reality software company to launch an immersive real-time collaboration platform for scientific discovery, and is changing the way we understand and interact with science at the molecular level. The software environment allows users to visualize, modify, and simulate proteins, chemical compounds, and nucleic acids to accelerate scientific decision making. The platform facilitates effective communication of data and integrates with existing computational chemistry workflows—features that have led to the adoption of the San Diego–based company's enterprise solution by several pharmaceutical and biotech companies worldwide.
Download Nanome for free today.
Affiliates + Partnerships
